A woman with deletion 14q as well as inversion 14 is presented, and physical signs are compared with those of patients with deletion long arm 13. No previous case of deletion long arm 14 has been published.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1013686PMC
http://dx.doi.org/10.1136/jmg.15.3.236DOI Listing

Publication Analysis

Top Keywords

deletion 14q
8
deletion long
8
long arm
8
deletion
4
14q pericentric
4
pericentric inversion
4
inversion woman
4
woman deletion
4
14q well
4
well inversion
4

Similar Publications

Background: Segmental chromosome aberrations, defined as presence of aberrations, deletion, or imbalance in the chromosomal arms, have long been considered as a predictor of poor prognosis of patients with neuroblastoma. The objective of this meta-analysis is to quantitively analyze the hazard ratios (HRs) of different whole or segmental chromosome aberrations for overall survival (OS) rate or event-free survival (EFS) rate of patients with neuroblastoma.

Methods: Relevant studies about chromosome, neuroblastoma, predictor, prognosis, and survival published from the inception to April 2023 in the databases of PubMed, Embase, and Web of Science were searched, screened, and reviewed.

View Article and Find Full Text PDF

Genomic profiles and clinical presentation of chordoma.

Acta Neuropathol Commun

August 2024

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Article Synopsis
  • Chordoma is a rare bone cancer affecting mainly adults, with an average diagnosis age of 45.5 years; it is most commonly found in the clivus, spinal column, and sacrum.
  • A large majority of patients (97.5%) underwent surgery, and many also received supplementary treatments; however, no significant cancer types appeared frequently among patients' families aside from the most common cancers.
  • Genomic analysis of tumor samples revealed recurrent mutations, notably in PIK3CA, and differences in genetic alterations based on the tumor location, indicating a complex relationship between tumor genetics and clinical outcomes.
View Article and Find Full Text PDF

RanGAP1 maintains chromosome stability in limb bud mesenchymal cells during bone development.

Cell Signal

August 2024

Department of Spine Surgery, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Dongguan 523059, China; Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China. Electronic address:

Background: Bone development involves the rapid proliferation and differentiation of osteogenic lineage cells, which makes accurate chromosomal segregation crucial for ensuring cell proliferation and maintaining chromosomal stability. However, the mechanism underlying the maintenance of chromosome stability during the rapid proliferation and differentiation of Prx1-expressing limb bud mesenchymal cells into osteoblastic precursor cells remains unexplored.

Methods: A transgenic mouse model of RanGAP1 knockout of limb and head mesenchymal progenitor cells was constructed to explore the impact of RanGAP1 deletion on bone development by histomorphology and immunostaining.

View Article and Find Full Text PDF

Plasma cell leukemia with soft tissue involvement; reporting a rare case.

Leuk Res Rep

January 2024

Department of Pathology and Laboratory Medicine, Lenox Hill Hospital, Northwell Health, NY, USA.

Plasma cell leukemia (PCL) is a rare aggressive variant of multiple myeloma. PCL is diagnosed when clonal plasma cells constitute more than 20 % of the total circulating leukocytes or when the absolute plasma cell count exceeds 2 × 10 /L. Extramedullary involvement including cavity effusion is frequently seen at the time of diagnosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!